TrialThe Journal of infectious diseases2023

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).

Podjanee Jittamala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.